CLAYTON — Researchers at Grifols hope they can use plasma from recovered COVID-19 patients to develop a targeted treatment for the coronavirus, the company announced …
This content is only avaiable to subscribers. If you are a subscriber, please log in to your account
If you already have an account, log in for continued access.
Current print subscribers can activate a website
account by clicking here.
Please consider supporting community journalism by subscribing.
614 E. Market St. Smithfield, North Carolina 27577 919-284-2295